1556P - Circulating tumour DNA (ctDNA) analysis depicts mechanisms of resistance and tumour response to BRAF inhibitors in BRAF-mutant non-small cell lung cancer (NSCLC)
Autor: | Ortiz - Cuaran, S. 1, Mezquita, L. 2, Swalduz, A. 3, Aldea, M. 2, Mazieres, J. 4, Jovelet, C. 2, Lacroix, L. 5, Pradines, A. 6, Avrillon, V. 7, MahierAït Oukhatar, C. 8, Hoog-Labouret, N. 9, Howarth, K. 10, Guichou, J.-F. 11, Morris, C. 10, Green, E. 10, Perol, M. 12, Besse, B. 13, Blay, J.-Y. 14, Saintigny, P. 15, Planchard, D. 5 |
---|---|
Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v641-v641 |
Databáze: | ScienceDirect |
Externí odkaz: |